Tag: Genfit
Genfit: little reaction to the acquisition of the Swiss Versantis – 09/19/2022 at 10:11
(CercleFinance.com) – Genfit announced on Monday the acquisition of the Swiss biopharmaceutical company Versantis with a view to enriching its portfolio of products in liver diseases. In a press release,…
Genfit: Little reaction to the acquisition of the Swiss Versantis
Read also (CercleFinance.com) – Genfit announced on Monday the acquisition of the Swiss biopharmaceutical company Versantis with a view to enriching its portfolio of products in liver diseases. In a…
Abnormal volumes on today’s session: Genfit
During this trading session on Friday August 12, 2022, abnormal trading volumes were detected on the French market. Today, it is the Genfit share that stands out, with trading up…
A good probability of success for Genfit after a bitter failure
The new ongoing phase III study has earned Ipsen confidence and builds on broad phase II success. A good probability of success for Genfit after a bitter failure | Photo…
Genfit: appointment to the Board of Steven Hildemann – 05/27/2022 at 10:34
(CercleFinance.com) – Genfit today announced the results of its Combined General Meeting convened for May 25, 2022. The quorum met on first call was 25.16% and enabled all of the…
Genfit: objective achieved?
By Hector Chaunu Published on 08/04/2022 at 11:57 Genfit fell 2% to 3.60 euros this Friday noon. In 2021, operating income amounted to €85.6…
Genfit: profits made in 2021
(CercleFinance.com) – Genfit announces that it recorded a net result of 67.3 million euros for 2021, against a loss of 101.2 million the previous year, and an operating result of…
Genfit: schedule to follow
Through Claude Leguilloux Published on 01/25/2022 at 07:36 (Boursier.com) — Genfit , a late-stage biopharmaceutical company committed to improving the lives of patients with severe chronic liver disease, announces its…
Genfit: gains more than 3%, a broker raises its target
(CercleFinance.com) – Genfit is up more than 3% in Paris, benefiting from the analysis of Oddo qio maintains its ‘outperformance’ rating on the title, with a price target raised to…
Ipsen Pharma: crosses 5% of Genfit capital – 12/27/2021 at 12:52
(CercleFinance.com) – Ipsen Pharma declared to the AMF that it crossed the thresholds of 5% of the capital and voting rights of Genfit on December 22, 2021, and held 8%…
Genfit: Ipsen Pharma crosses 5% of capital and votes
(CercleFinance.com) – Ipsen Pharma declared to the AMF that it crossed the thresholds of 5% of the capital and voting rights of Genfit on December 22, 2021, and held 8%…
Genfit: Ipsen Pharma crosses 5% of capital and votes – 12/24/2021 at 11:38
(CercleFinance.com) – Ipsen Pharma declared to the AMF that it crossed the thresholds of 5% of the capital and voting rights of Genfit on December 22, 2021, and held 8%…